Skip to main content

Month: March 2022

Progress Releases 35+ New DataDirect Connectors for Strategic Decision-Making

New connectors provide real-time access to Foursquare, Google Calendar, Twitter, WordPress, YouTube, Zoom and more to help organizations bridge the data gap for analytics-driven effectiveness BEDFORD, Mass., March 21, 2022 (GLOBE NEWSWIRE) — Progress (Nasdaq: PRGS), the trusted provider of infrastructure software, today announced the availability of 35+ new Progress® DataDirect® connectors to help organizations overcome the challenge of accessing data and business intelligence from disparate applications. Adding to an industry-leading portfolio of pre-built connectors, the new series provides fast and direct access to a variety of popular data sources, including Foursquare, Google Calendar, Twitter, WordPress, YouTube, Zoom and more. Data connectivity is increasingly critical to companies’ ability to win, serve and retain their...

Continue reading

Teladoc Health Announces Virtual Care Transformation Model for Employers

This first-of-its-kind framework provides a clear roadmap to evolve virtual health care benefits PURCHASE, NY, March 21, 2022 (GLOBE NEWSWIRE) — Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, today announced a first-of-its-kind Virtual Care Transformation Model. This strategic framework helps employers and health plans to assess and advance their healthcare programs by proactively integrating virtual care as a way of improving access, lowering costs and providing better health outcomes to individuals. A national study conducted by Teladoc Health revealed that employers are seeking solutions that provide a full spectrum of health and well-being supports, with 70% planning to fully implement or be close to implementing a whole-person virtual care strategy in the next 3 years. The study also showed that...

Continue reading

LPL Financial Advisors Named to Barron’s 2022 List of Top Financial Advisors in America

CHARLOTTE, N.C., March 21, 2022 (GLOBE NEWSWIRE) — LPL Financial LLC (Nasdaq:LPLA) announced today that 22 advisors affiliated with LPL have been ranked on Barron’s 2022 list of the Top 1,200 Financial Advisors in America, up from 17 last year. As part of the criteria, Barron’s evaluates U.S.-based financial advisors based on several factors, including the quality of their practice, assets under management and philanthropic work*. The independent, LPL-affiliated advisors recognized in the 2022 list include:Michael Allard, CalBay Investments Inc, Danville, Calif. Michael Axelrod, Bleakley Financial Group, Fairfield, N.J. Mark Brown, Brown & Company, Denver, Colo. Vince Cimino, Wealth Enhancement Group, Clinton, Wis. Jack Cooney, Bleakley Financial Group, Fairfield, N.J. Mark Cortazzo, Wealth Enhancement Group, Parsippany,...

Continue reading

3rd Gen AMD EPYC Processors with AMD 3D V-Cache Technology Deliver Outstanding Leadership Performance in Technical Computing Workloads

— Newest addition to 3rd Gen AMD EPYC™ family features 768MB of L3 cache, drop-in platform compatibility, and modern security features — — The EPYC processor ecosystem for technical computing grows with solutions from major OEMs, ODMs, SIs, ISVs and the cloud — SANTA CLARA, Calif., March 21, 2022 (GLOBE NEWSWIRE) — AMD (NASDAQ: AMD) announced the general availability of the world’s first data center CPU using 3D die stacking, the 3rd Gen AMD EPYC™ processors with AMD 3D V-Cache™ technology, formerly codenamed “Milan-X.” Built on the “Zen 3” core architecture, these processors expand the 3rd Gen EPYC CPU family and can deliver up to 66 percent performance uplift across a variety of targeted technical computing workloads versus comparable, non-stacked 3rd Gen AMD EPYC processors.1,2 These new processors feature the industry’s largest...

Continue reading

Canterbury Park Holding Corporation Reports Record 2021 Fourth Quarter Results

SHAKOPEE, Minn., March 21, 2022 (GLOBE NEWSWIRE) — Canterbury Park Holding Corporation (“Canterbury” or the “Company”) (NASDAQ: CPHC), today reported record financial results for the fourth quarter and full year ended December 31, 2021. ($ in thousands, except per share data and percentages)  Three Months Ended December 31,   Twelve Months Ended December 31,  2021   2020   Increase(3)   2021   2020   IncreaseNet revenues $ 13,955   $ 6,123     128 %   $ 60,400   $ 33,140   82 %                       Net income (1) $ 6,620   $ 139     NM   $ 11,798   $ 1,062   1,011 %                       Adjusted EBITDA(2) $ 3,360   $ (27 )   NM   $ 13,471   $ 806   1,572 %                       Basic EPS $ 1.38   $ 0.03     NM   $ 2.47   $ 0.23   974 %Diluted EPS $ 1.37   $ 0.03     NM   $ 2.44   $ 0.23   961 %(1) Net...

Continue reading

WillScot Mobile Mini Acquires Blast Resistant Module Lease Portfolio

PHOENIX, March 21, 2022 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini” or the “Company”) (Nasdaq: WSC), the North American leader in modular space and portable storage solutions, today announced that it acquired a portfolio of blast resistant modules and related assets from Satellite Structures, Inc. The transaction was funded with cash on hand and borrowings under the Company’s revolving credit agreement. Brad Soultz, Chief Executive Officer, commented, “As the leader in modular space and storage solutions, I am excited to build upon our industry leading safety culture and technical expertise to expand our offering of blast resistant modules, making WillScot Mobile Mini a provider of choice in this segment of the modular market. This transaction creates new opportunities to grow our offering with...

Continue reading

Compass Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Ended 2021 with $144.5 million in cash and cash equivalents CTX-009 (DLL4 X VEGF-A bispecific antibody) Global Phase 2 study in patients with advanced biliary tract cancers (BTC) is progressing well; the response criteria required to advance the study to its second stage have been met (ORR = 29% for the first 17 evaluable patients) The Company plans to update the results from the first stage of the BTC study in Q2 of 2022 The FDA cleared the CTX-009 IND in January; US sites are expected to start opening in Q2 of 2022 and to begin dosing patients in Q3 of 2022 CTX-471 (CD137 agonist): three partial responses were seen in the monotherapy study of patients with solid tumors who have previously progressed on PD-1 or PD-L1 therapyBOSTON, March 21, 2022 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage,...

Continue reading

authID.ai Announces 2021 Operational and Financial Results

Company Completes Financing of $22.5 MillionManagement to Host Conference Call Today at 8:30 a.m. EDT LONG BEACH, N.Y., March 21, 2022 (GLOBE NEWSWIRE) — authID.ai [Nasdaq: AUID] a leading provider of secure, mobile, biometric identity authentication, today reported financial and operating results for the year ended December 31, 2021. Since the Company’s rebrand to authID.ai in June 2021, significant progress has been made on its strategic objectives, including completing an uplisting to Nasdaq and an $11.5M investment round in August. authID also strengthened and diversified its Board of Directors and management team which has focused on promoting the Company’s brand, and innovating its Verified Identity as a Service (IDaaS) platform to enhance the user experience and drive adoption. The issuance and notice of allowance of patents...

Continue reading

BlackRock® Canada Announces March Cash Distributions for the iShares® ETFs

TORONTO, March 21, 2022 (GLOBE NEWSWIRE) — BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, Inc. (NYSE: BLK), today announced the March 2022 cash distributions for the iShares ETFs listed on the TSX or NEO which pay on a monthly or quarterly basis. Unitholders of record of a fund on March 28, 2022 will receive cash distributions payable in respect of that fund on March 31, 2022. Details regarding the “per unit” distribution amounts are as follows:Fund Name FundTicker CashDistributionPer Unit ($)iShares 1-10 Year Laddered Corporate Bond Index ETF CBH 0.044iShares 1-5 Year Laddered Corporate Bond Index ETF CBO 0.037iShares S&P/TSX Canadian Dividend Aristocrats Index ETF CDZ 0.093iShares Equal Weight Banc & Lifeco ETF CEW 0.048iShares Global...

Continue reading

Life Science Instrumentation Market Size [2021-2028] | Growth, Share, Industry Trends Forecast

Life Science Instrumentation Market to Benefit from the Increasing Awareness Regarding Early Diagnosis and Treatment | Fortune Business Insights Pune, India, March 21, 2022 (GLOBE NEWSWIRE) — The global life science instrumentation market will benefit from recent advancements in the life science instrumentation industry. According to a report by Fortune Business Insights, titled “Life Science Instrumentation Market Size, Share and Global Trend By Technology (PCR, Spectroscopy, Microscopy, Chromatography, Electrophoresis, Next-generation sequencing (NGS), Flow Cytometry, Centrifuges), By Application (Clinical and Diagnostic, Research), By Distribution Channel (Hospitals and diagnostic laboratories, Pharmaceutical and biotechnology companies, Academic & Research institutions) and Geography Forecast till 2026,” the market will...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.